ONESOURCE

Onesource Specialty Pharma Ltd.

1,583.40+14.4 (+0.92%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Onesource Specialty Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual ReportsFY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Onesource Specialty Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Analyst / Investor Meet3 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of the investor presentation
  2. Newspaper Publication1 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper advertisement confirming the dispatch of the notice convening the 19th AGM of the Company and Remote e-voting
  3. AGM31 Aug 2026
    Notice Of The 19Th AGM Dated September 23, 2026
    Intimation of the Notice of the 19th AGM (2nd AGM after listing), to be held on September 23, 2026 at 5:00 pm through Video Conferencing or other Audio Visual Means
  4. Business Responsibility and Sustainability Reporting (BRSR)31 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report for the FY 2026
  5. Reg. 34 (1) Annual Report31 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report for FY 2025-26
  6. Reg. 34 (1) Annual Report31 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report for FY 2025-26
  7. Analyst / Investor Meet31 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Investors called scheduled on September 03, 2026 at 10:00 AM.
  8. Newspaper Publication29 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper advertisement regarding the 19th Annual General Meeting of the Company
  9. Credit Rating18 Aug 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Intimation of Credit Rating issued by India Ratings and Research Private Limited vide press release dated August 17, 2026
  10. Change in Management27 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Changes in Senior Management Personnel (SMP) of the Company - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  11. Newspaper Publication26 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Intimation about publication of newspaper advertisement- Extract of unaudited Standalone and Consolidated financial results for the quarter ended June 30, 2026.
  12. Analyst / Investor Meet25 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Audio Recording of Earnings call pertaining to the Unaudited Financial Results for the quarter ended June 30, 2026
  13. Allotment of ESOP / ESPS24 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Intimation of allotment of 2,900 ESOPs of Re.1 each under ONESOURCE ESOP 2021
  14. Press Release / Media Release24 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    OneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY
  15. Change in Management24 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Changes in the Senior Managament Personnel of the Company-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  16. Outcome of Board Meeting24 Jul 2026
    Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated July 24, 2026, For The Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026
    Outcome of the Board meeting dated July 24, 2026, for the approval of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026.
  17. Analyst / Investor Meet21 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Call to be held on July 25, 2026.
  18. Board Meeting20 Jul 2026
    Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026.
    Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited financial ....
  19. General14 Jul 2026
    Onesource Specialty Pharma And Formycon AG Announce
    OneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars
  20. General9 Jul 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
    We refer to the intimation made earlier today by Dr. Reddy''s Laboratories (DRL) regarding delay in commercial supplies of Semaglutide. Refer intimation attached.

Frequently Asked Questions

Where can I download the annual report of Onesource Specialty Pharma Ltd.?
Annual reports of Onesource Specialty Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Onesource Specialty Pharma Ltd.?
Quarterly earnings results and presentations of Onesource Specialty Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Onesource Specialty Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Onesource Specialty Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Onesource Specialty Pharma Ltd.?
Investor presentations and annual day presentations of Onesource Specialty Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Onesource Specialty Pharma Ltd.?
Corporate announcements and regulatory filings of Onesource Specialty Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Onesource Specialty Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Onesource Specialty Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Onesource Specialty Pharma Ltd.?
The ISIN (International Securities Identification Number) of Onesource Specialty Pharma Ltd. is INE013P01021. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Onesource Specialty Pharma Ltd. listed?
Onesource Specialty Pharma Ltd. is listed on NSE and BSE. The NSE symbol is ONESOURCE and the BSE code is -.
Where can I find the shareholding pattern of Onesource Specialty Pharma Ltd.?
The quarterly shareholding pattern of Onesource Specialty Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Onesource Specialty Pharma Ltd. on Sharpely?
Share price data for Onesource Specialty Pharma Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.